S. 3311 · 118th Congress (2023–2025)
American Made Pharmaceuticals Act of 2023
This bill requires the Centers for Medicare & Medicaid Services to conduct a demonstration program that gives preference to domestically manufactured drugs under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
The program must be conducted in at least eight states and for at least seven years. Applicable drugs include critical drugs that are needed to respond to a public health emergency and that have a vulnerable global supply chain. Preference may take the form of reduced cost-sharing, preferential treatment on formularies, bonus payments, and other specified methods.
Show official title
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 3311’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Tina Smith (D-MN)
- Cosponsors
2 cosponsors
1 original · 1 later
- Sen. Tom Cotton (R-AR)· Original · Nov 15, 2023
- Sen. Michael F. Bennet (D-CO)· Later · Dec 6, 2023
- Policy area
- Health
- Subjects
- Buy American requirements
- Child health
- Congressional oversight
- Drug therapy
- Emergency medical services and trauma care
- Health care costs and insurance
- Health technology, devices, supplies
- Infectious and parasitic diseases
6 more
- Manufacturing
- Medicaid
- Medicare
- Poverty and welfare assistance
- Prescription drugs
- Public contracts and procurement
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate committee → No further action before the 118th Congress ended.
Committees
Jul 25, 2024 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
American Made Pharmaceuticals Act of 2023
Display title, Short title · Introduced in Senate
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
Official title · Introduced in Senate